中文English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R

留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

穿膜蛋白1和基质金属蛋白酶9在胆管癌中的表达及意义

王晓茜 唐南洪 李秀金 陈燕凌

引用本文:
Citation:

穿膜蛋白1和基质金属蛋白酶9在胆管癌中的表达及意义

DOI: 10.3969/j.issn.1001-5256.2014.01.03.016
基金项目: 

福建省卫生厅青年科研课题资助项目(2008-2-14); 

详细信息
  • 中图分类号: R735.8

Expression and clinical significance of DLK1 and MMP-9 in cholangiocarcinoma

Research funding: 

 

  • 摘要:

    目的通过观察胆管癌组织中穿膜蛋白1(DLK1)与基质金属蛋白酶9(MMP-9)的表达,分析两者的临床意义及相关性。方法收集2001-2010年96例胆管癌患者癌组织,20例正常人胆管组织作为对照,采用SP免疫组织化学法检测组织中DLK1与MMP-9的表达。组间比较采用卡方检验,相关性检验采用Spearman相关分析。结果 DLK1与MMP-9在胆管癌中的阳性表达率分别为59.38%和79.17%,2者显著高于在正常胆管组织中的表达(0和15%),差异有统计学意义(χ2=23.35、31.37,P<0.05)。胆管癌中DLK1的表达与肿瘤的分化程度相关(χ2=7.46,P<0.05);MMP-9的表达与肿瘤的分化程度、淋巴结转移相关(χ2=7.28、9.67,P<0.05),与性别、年龄、肿瘤组织大小无关(p>0.05)。两者在胆管癌组织中的表达呈正相关(r=0.41,P<0.05)。结论 DLK1与MMP-9在胆管癌中高表达,且两者呈正相关,提示可能与胆管癌的发生、发展、侵润、转移有关,其表达的检测为胆管癌的诊断及治疗提供一定的参考依据。

     

  • [1]GENG JH, YUAN JF, WU M, et al.Distribution on epidemiological survey and risk factor for gallbladder cancer[J].J Clin Exp Med, 2012, 11 (16) :1336-1337. (in Chinese) 耿金宏, 袁金凤, 吴鸣, 等.胆囊癌流行分布及高危因素探讨研究[J].临床和实验医学杂志, 2012, 11 (16) :1336-1337.
    [2]ZHU NL, ASAHINA K, WANG J, et al.Hepatic stellate cell-derived Delta-like Homolog 1 (DLK1) protein in liver regeneration[J].J Biol Chem, 2012, 287 (13) :10355-10367.
    [3]PAN RL, WANG P, XIANG LX, et al.Delta-like 1 serves as a new target and contributor to liver fibrosis down-regulated by mesenchymal stem cell transplantation[J].J Biol Chem, 2011, 286 (14) :12340-12348.
    [4]HUANG J, ZHANGX, ZHANG M, et al.Up-regulation of DLK1as an imprinted gene could contribute to humanhepatocellular carcinoma[J].Carcinogenesis, 2007, 28 (5) :1094-1103.
    [5]HUANG CC, CHUANG JH, HUANG LL, et al.The human Delta-like 1 homologue is implicated in the progression of liver fibrosis in biliary atresia[J].J Pathol, 2004, 202 (2) :172-179.
    [6]LEE SO, JEONG YJ, KIM M, et al.Suppression of PMA-induced tumor cell invasion by capillarisin via the inhibition of NFkappa B-dependent MMP-9 expression[J].Biochem Biophys Res Commun, 2008, 366 (4) :1019-1024.
    [7]ZHAO M, GAO Y, WANG L, et al.Overexpression of integrinlinked kinase promotes lung cancer cell migration and invasion via NF-κB-mediated upregulation of matrix metalloproteinase-9[J].Int J Med Sci, 2013, 10 (8) :995-1002.
    [8]SHIRABE K, SHIMADA M, KAJIYAMA K, et al.Expression of matrix metalloproteinase-9 in surgically resected intrahepatie cholangiocarcinoma[J].Surgery, 1999, 126 (5) :842-846.
    [9]DENNING MF, DLUGOSZ AA, CHENG C, et al.Cross-talk between epidermalgrowth factor receptor and protein kinase D during calcium induceddifferentiation of keratinocytes[J].Exp Dermatol, 2000, 9:192-199.
    [10]ELLENRIEDER V, HENDLER SF, RUHLAND C, et al.TGF-β-induced invasiveness of pancreatic cancer cells is mediated by matrix metalloproteinase-2 and the urokinase plasminogen activator system[J].Int J Cancer, 2001, 93 (2) :204-211.
    [11]ABOUNADER R, RANGANATHAN S, LAL B, et al.Reversion of human glioblastoma malignancy by U1 small nuclear RNA/ribozyme targeting of scatter factor/HGF and c-met expression[J].J Natl Cancer Inst, 1999, 91 (18) :1548-1556.
    [12]SUNDARAM MV.The love hate relationship between Ras and Notch[J].Genes Dev, 2005, 19 (16) :1825-1839.
    [13]Huang B, Zhao GZ.Expressions of AnnexinⅡand Ki-6 in cholangiocarcinoma and their clinicopathological significance[J].J Clin Hepatol, 2011, 27 (2) :178-180. (in Chinese) 黄波, 赵国忠.AnnexinⅡ和Ki-67在胆管癌中的表达及意义[J].临床肝胆病杂志, 2011, 27 (2) :178-180.
    [14]KHAN SA, TOMAS HC, TOLEDANO MB, et al.P53 mutations in human cholangiocarcinoma:a review[J].Liver Int, 2005, 25 (4) :704-716.
  • 加载中
计量
  • 文章访问数:  3169
  • HTML全文浏览量:  22
  • PDF下载量:  685
  • 被引次数: 0
出版历程
  • 出版日期:  2014-03-20
  • 分享
  • 用微信扫码二维码

    分享至好友和朋友圈

目录

    /

    返回文章
    返回